Trials / Completed
CompletedNCT01737307
Effect of Fluoride Varnish and CPP-ACP on Oral and Salivary Symptoms During Chemotherapy
Effect of Fluoride Varnish and CPP-ACP Paste on Oral and Salivary Symptoms of Patients Under Chemotherapy: A Double-blind Clinical Trial
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Azad University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 12 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to investigate the effect of Fluoride varnish and Casein Phospho-Peptide Amorphous Calcium Phosphate (CPP-ACP) containing paste on oral symptoms and salivary characteristics in patients under chemotherapy.
Detailed description
Chemotherapy as a treatment method of cancers, affects different parts of the oral cavity such as oral mucosa, teeth and salivary glands caused by salivary glands dysfunction during chemotherapy.Oral status of patients under chemotherapy will be affected by consumption of the drugs and their side effects such as reduction of the saliva, dryness of the oral cavity, changes in bacterial balance, oral mucosa damage, bleeding due to irritation of the tissues, xerostomia, dental caries, burning sensation, dysgeusia and dysphagia. No effective preventive protocol has been presented for oral care during chemotherapy. Patients who were met the inclusion criteria (aged over 12, diagnosed to have cancer by an oncologists and needed chemotherapy drugs, had at least 20 teeth, had no other pathologic lesion in their oral cavity, were not treated by radiotherapy and did not have specific systemic diseases or head and neck cancer) were selected for the study. the participants were evaluated according to oral and salivary symptoms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluoride varnish | Fluoride Varnish (NaF 5%) |
| OTHER | Oral Hygiene | Oral hygiene followed. |
| DRUG | CPP-ACP | CPP-ACP paste was applied by patient, once daily. |
Timeline
- Start date
- 2011-03-01
- Primary completion
- 2011-06-01
- Completion
- 2011-12-01
- First posted
- 2012-11-29
- Last updated
- 2012-11-29
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01737307. Inclusion in this directory is not an endorsement.